MedTrace Logo

Safety of Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With Allergic Rhinitis or Chronic Idiopathic Urticaria (Study P04446AM1)(COMPLETED)

NCT00723736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-02-09

Study results available
· View outcomes & findings →

Summary

The objective of this non-interventional study is to evaluate the safety of Aerius syrup in pediatric patients aged 1-5 years old with allergic rhinitis or chronic idiopathic uticaria. The patients will receive 2.5 ml (1.25 mg) once daily.

Conditions

  • Rhinitis
  • Urticaria

Interventions

DRUG

Desloratadine

2.5 ml (1.25 mg) once daily

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Eligibility

Min Age
1 Year
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-06-30
Completion
2008-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00723736 on ClinicalTrials.gov